Roper Technologies, Inc.ROP
NASDAQ • Industrials
$355.85
P/E
25.07
PEG
—
FCF Yield
—
Rev Growth YoY
+1226.0% YoY
Gross Margin
6924.0%
Health Score
5/10
D/E Ratio
0.47
Confidence
LOW
Business Snapshot
Roper Technologies is a diversified technology company operating across software, medical, and industrial verticals, with a focus on niche market leadership and recurring revenue streams. The stock currently trades at $355.85, sitting 39% below its 52-week high of $584.03, suggesting significant drawdown from recent peaks. With key market capitalisation data unavailable in the current payload, precise cap-tier classification cannot be confirmed, though Roper has historically operated as a large-cap industrial technology firm.
Financial Health
Score: 5/10
Roper's balance sheet shows a conservative debt posture, with a Debt/Equity ratio of 0.47x — a level that signals manageable leverage. However, a Current Ratio of just 0.52x is a meaningful concern, indicating that current liabilities significantly exceed current assets, which could pressure short-term liquidity...
Risk Assessment
- EARNINGS DETERIORATION: Earnings growth of -106% YoY represents a collapse in profitability that directly contradicts the reported revenue surge of 1,226%.
- LIQUIDITY: Current ratio of 0.52x is well below the conventional safety threshold of 1.0x, indicating current liabilities more than double current assets.
- TECHNICAL WEAKNESS: A confirmed death cross (50-day MA crossing below 200-day MA) with price trading below both moving averages signals sustained bearish momentum.
- DATA QUALITY: Gross margins reported at 6,924% and net margins at 1,944% are statistically impossible under standard accounting and indicate corrupted or misreported data in the payload, materially undermining financial analysis.
- EARNINGS CONSISTENCY: ROP beat analyst earnings estimates in only 1 of the last 4 reported quarters, suggesting persistent forecast misses.
---...
**Score: 5/10** Roper's balance sheet shows a conservative debt posture, with a Debt/Equity ratio of 0.47x — a level that signals manageable leverage. However, a Current Ratio of just 0.52x is a meaningful concern, indicating that current liabilities significantly exceed current assets, which could pressure short-term liquidity. Free cash flow data is unavailable in this payload, preventing a full assessment of the company's ability to self-fund operations or return capital to shareholders, which limits conviction in any health score. ---
- **EARNINGS DETERIORATION:** Earnings growth of -106% YoY represents a collapse in profitability that directly contradicts the reported revenue surge of 1,226%. - **LIQUIDITY:** Current ratio of 0.52x is well below the conventional safety threshold of 1.0x, indicating current liabilities more than double current assets. - **TECHNICAL WEAKNESS:** A confirmed death cross (50-day MA crossing below 200-day MA) with price trading below both moving averages signals sustained bearish momentum. - **DATA QUALITY:** Gross margins reported at 6,924% and net margins at 1,944% are statistically impossible under standard accounting and indicate corrupted or misreported data in the payload, materially undermining financial analysis. - **EARNINGS CONSISTENCY:** ROP beat analyst earnings estimates in only 1 of the last 4 reported quarters, suggesting persistent forecast misses. ---
Unlock the full AI report
Full 8-section analysis includes:
Metric deep-dives